Cleared Traditional

K182063 - VITROS Chemistry Products CRBM Slides, VITROS Chemistry Products CREA Slides, VITROS Chemistry Products TBIL Slides, VITROS XT 7600 Integrated System (FDA 510(k) Clearance)

Oct 2018
Decision
90d
Days
Class 2
Risk

K182063 is an FDA 510(k) clearance for the VITROS Chemistry Products CRBM Slides, VITROS Chemistry Products CREA Slides, VITROS Chemistry Products TBIL Slides, VITROS XT 7600 Integrated System. This device is classified as a Enzymatic Method, Creatinine (Class II - Special Controls, product code JFY).

Submitted by Ortho-Clinical Diagnostics, Inc. (Rochester, US). The FDA issued a Cleared decision on October 30, 2018, 90 days after receiving the submission on August 1, 2018.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1225.

Submission Details

510(k) Number K182063 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2018
Decision Date October 30, 2018
Days to Decision 90 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JFY — Enzymatic Method, Creatinine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1225